Characteristics of infectious diseases in the elderly;Particularites des maladies infectieuses chez le sujet âgé

Presse Medicale

Volumn 31, Issue 32, 2002, Pages 1517-1520

  Merrien, Dominique ^a  

^a Centre Hospitalier Compiegne   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID; ANTIINFECTIVE AGENT; BACTERIAL VACCINE;

AGED; AGING; GERIATRIC DISORDER; GERIATRIC PATIENT; HERPES ZOSTER; HUMAN; IMMUNE DEFICIENCY; INFECTION; INFECTION PREVENTION; INFECTION SENSITIVITY; INFECTIOUS COMPLICATION; INFLUENZA VACCINATION; MENINGITIS; MORTALITY; RESPIRATORY TRACT INFECTION; REVIEW; SEPTICEMIA; SYMPTOMATOLOGY; TETANUS; TUBERCULOSIS; URINARY TRACT INFECTION; ADOLESCENT; ADULT; AGE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; RISK FACTOR; SEPSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL VACCINES; COHORT STUDIES; FEMALE; HERPES ZOSTER; HUMANS; INFECTION; INFLUENZA VACCINES; MALE; MENINGITIS; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SEPSIS; TETANUS TOXOID; TUBERCULOSIS; URINARY TRACT INFECTIONS;

EID: 2242472908     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Yoshikawa TT. Perpective: aging and infectious diseases: past, present and future. J Infect Dis 1997; 176: 1053-7.
2. Bouchon JP, Durand-Gasselin B. Atypies sémiologiques, difficultés diagnostiques. In: Infections chez les sujets âgés, Veyssier P. Ellipses, Paris, 1997; 82-89.
3. Jokinen C, Heiskanen L, Juvonen H et al. Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland. Am J Epidemiol 1993; 137: 977-88.
4. Mandell LA. Community-acquired pneumonia. Etiology, epidemiology and treatment. Chest 1995; 108: 35-42.
5. Sullivan RJ, Dowdle WR, Marine WM, Hierholzer JC. Adult pneumonia in a general hospital. Etiology and host risk factors. Arch Intern Med 1972; 129: 935-42.
6. Feagan BG, Marrie TJ, Lau CY, Wheeler SL. Wong Cj, Vanderroot MK. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. Can Med Assoc J 2000; 162: 1415-20.
7. Marie TJ. Community-acquired pneumonia in the elderly. Clin Inf Dis 2000; 31: 1066-78.
8. El Solh AA, Sikka P, Ramadan F, Davies J. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 2001; 163: 645-651.
9. Marrie TJ. Epidemiology of community-acquired pneumonia in the elderly. Sem Respir Infect 1990; 5: 260-8.
10. Leroy O, Bosquet C, Vandenbussche C et al. Community-acquired pneumonia in the intensive care unit: epidemiological and prognosis data in older people. J Am Geriatr Soc 1999; 47: 539-46.
11. Lieberman D, Schlaeffer F, Porath A. Community-acquired pneumonia in old age: a prospective study of 91 patients admitted from home. Age Ageing 1997; 26: 69-75.
12. Riquelme R, Torres A, Ebiary WM et al. Community-acquired pneumonia in the elderly. Am J Respir Crit Care Med 1997; 156: 1908-14.
13. Metlay JP, Schulz R, Li YH et al. Influence of age on symptoms at presentation on patients with community-acquired pneumonia. Arch Inter Med 1997; 157: 1453-9.
14. Torres A, Dorca J, Zalacain R et al. Community-acquired pneumonia in chronic obstructive pulmonary disease: a spanish multicenter study. Am J Respir Crit Care Med 1996; 154: 1456-61.
15. Ruiz M, Ewig S, Marcos MA et al. Etiology of community-acquired pneumonia: impact of age, comorbidity and severity. Am J Respir Crit Care Med 1999; 160: 397-405.
16. Conférence de consensus des infections respiratoires. Med Mal Infect 2000; 30: 573-80.
17. Guibert J, Destrée D. L'infection urinaire du sujet âgé. Med Mal Infect 1988 (n° spécial mai): 332-6.
18. Akpabie A, Prieur B. Germes urinaires et leur sensibilité aux antibiotiques en gériatrie. Med Mal infect 2001; 31: 641-7.
19. Le Moal G, Roblot F, Paccalin M, Pasdeloup T, Roblot P, Becq-Giraudon B. Particularités des méningites du sujet âgé. Rev Med Interne 2000; 21: 844-53.
20. Perez-Guzman C, Vargas MH, Torres-Cruz A, Villarreal-Velarde H. Does aging modify pulmonary tuberculosis? A meta analytical review. Chest 1999; 116: 961-7.
21. Roblot F, Roblot P, Bourgoin A et al. Particularites de la tuberculose chez les sujets âgés. Rev Med Interne 1998; 19: 629-34.
22. Umeki S. Comparison of younger and elderly patients with pulmonary tuberculosis. Respiration 1989; 55: 75-83.
23. Davies PD. Tuberculosis in the elderly. J Antimicrob Chemoth 1994; 34: 93-100.
24. Meaume S. Particularités des infections à VZV chez le sujet âgé. Med Mal Infect 1998; 28 (spécial): 800-5.
25. Higa K, Mori M, Hirata K, Hori K, Manabe H, Dan K. Severity of skin lesions of herpes zoster at the worst phase rather than age and involved region most influences the duration of acute herpetic pain. Pain 1997; 69: 245-53.
26. Trivalle C, Feteanu D. Septicémies et bactériémies en gériatrie, Rev Geriatrie 2001; 26: 23-6.
27. McClelland RS, Fowler VG, Sanders LL et al. Staphylococcus aureus bacteremia among elderly vs younger adults patients. Arch Intern Med 1999; 159: 1244-7.
28. Gross PA, Hermogenes AW, Sacks GA, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the litterature. Ann Intern Med 1995; 123: 518-27.
29. Gerard Y. Vaccinations du sujet agé. La lettre de l'infectiologue 1997; suppl 6: 33-5.
30. Koivula I, Sten M, Leinonen M, Mäkelä PH. Clinical efficacy of pneumococcal vaccine in the elderly: a randomised, single-blind population-based trial. Am J Med 1997; 103: 281-90.
31. Christenson B, Lundbergh P, Hedlund J, Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet 2001, 357: 1008-11.
32. Alagappan K, Rennie W, Narang V, Auerbach C. Immunologic response to tetanus toxoid in geriatric patients. Annals Emerg Med 1997; 30: 459-62